Bioproducts From Euglena gracilis: synthesis and applications

Alexander Gissibl, Angela Sun, Andrew Care, Helena Nevalainen, Anwar Sunna

Research output: Contribution to journalReview articleResearchpeer-review

Abstract

In recent years, the versatile phototrophic protist Euglena gracilis has emerged as an interesting candidate for application-driven research and commercialisation, as it is an excellent source of dietary protein, pro(vitamins), lipids, and the β-1,3-glucan paramylon only found in euglenoids. From these, paramylon is already marketed as an immunostimulatory agent in nutraceuticals. Bioproducts from E. gracilis can be produced under various cultivation conditions discussed in this review, and their yields are relatively high when compared with those achieved in microalgal systems. Future challenges include achieving the economy of large-scale cultivation. Recent insights into the complex metabolism of E. gracilis have highlighted unique metabolic pathways, which could provide new leads for product enhancement by genetic modification of the organism. Also, development of molecular tools for strain improvement are emerging rapidly, making E. gracilis a noteworthy challenger for microalgae such as Chlorella spp. and their products currently on the market.
LanguageEnglish
Article number108
Number of pages16
JournalFrontiers in Bioengineering and Biotechnology
Volume7
DOIs
Publication statusPublished - 15 May 2019

Fingerprint

Euglena gracilis
Dietary Proteins
Vitamins
Metabolism
Lipids
Genetic Enhancement
Proteins
Technology Transfer
Microalgae
Chlorella
Dietary Supplements
Metabolic Networks and Pathways
paramylon
beta-1,3-glucan

Bibliographical note

Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Euglena gracilis
  • biosynthesis
  • dietary protein
  • vitamins
  • polyunsaturated fatty acids
  • wax esters
  • paramylon
  • large-scale cultivation

Cite this

@article{e33a11b93bc04e849331c9358445e594,
title = "Bioproducts From Euglena gracilis: synthesis and applications",
abstract = "In recent years, the versatile phototrophic protist Euglena gracilis has emerged as an interesting candidate for application-driven research and commercialisation, as it is an excellent source of dietary protein, pro(vitamins), lipids, and the β-1,3-glucan paramylon only found in euglenoids. From these, paramylon is already marketed as an immunostimulatory agent in nutraceuticals. Bioproducts from E. gracilis can be produced under various cultivation conditions discussed in this review, and their yields are relatively high when compared with those achieved in microalgal systems. Future challenges include achieving the economy of large-scale cultivation. Recent insights into the complex metabolism of E. gracilis have highlighted unique metabolic pathways, which could provide new leads for product enhancement by genetic modification of the organism. Also, development of molecular tools for strain improvement are emerging rapidly, making E. gracilis a noteworthy challenger for microalgae such as Chlorella spp. and their products currently on the market.",
keywords = "Euglena gracilis, biosynthesis, dietary protein, vitamins, polyunsaturated fatty acids, wax esters, paramylon, large-scale cultivation",
author = "Alexander Gissibl and Angela Sun and Andrew Care and Helena Nevalainen and Anwar Sunna",
note = "Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
year = "2019",
month = "5",
day = "15",
doi = "10.3389/fbioe.2019.00108",
language = "English",
volume = "7",
journal = "Frontiers in Bioengineering and Biotechnology",
issn = "2296-4185",
publisher = "Frontiers Research Foundation",

}

Bioproducts From Euglena gracilis : synthesis and applications. / Gissibl, Alexander; Sun, Angela; Care, Andrew; Nevalainen, Helena; Sunna, Anwar.

In: Frontiers in Bioengineering and Biotechnology, Vol. 7, 108, 15.05.2019.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Bioproducts From Euglena gracilis

T2 - Frontiers in Bioengineering and Biotechnology

AU - Gissibl,Alexander

AU - Sun,Angela

AU - Care,Andrew

AU - Nevalainen,Helena

AU - Sunna,Anwar

N1 - Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/5/15

Y1 - 2019/5/15

N2 - In recent years, the versatile phototrophic protist Euglena gracilis has emerged as an interesting candidate for application-driven research and commercialisation, as it is an excellent source of dietary protein, pro(vitamins), lipids, and the β-1,3-glucan paramylon only found in euglenoids. From these, paramylon is already marketed as an immunostimulatory agent in nutraceuticals. Bioproducts from E. gracilis can be produced under various cultivation conditions discussed in this review, and their yields are relatively high when compared with those achieved in microalgal systems. Future challenges include achieving the economy of large-scale cultivation. Recent insights into the complex metabolism of E. gracilis have highlighted unique metabolic pathways, which could provide new leads for product enhancement by genetic modification of the organism. Also, development of molecular tools for strain improvement are emerging rapidly, making E. gracilis a noteworthy challenger for microalgae such as Chlorella spp. and their products currently on the market.

AB - In recent years, the versatile phototrophic protist Euglena gracilis has emerged as an interesting candidate for application-driven research and commercialisation, as it is an excellent source of dietary protein, pro(vitamins), lipids, and the β-1,3-glucan paramylon only found in euglenoids. From these, paramylon is already marketed as an immunostimulatory agent in nutraceuticals. Bioproducts from E. gracilis can be produced under various cultivation conditions discussed in this review, and their yields are relatively high when compared with those achieved in microalgal systems. Future challenges include achieving the economy of large-scale cultivation. Recent insights into the complex metabolism of E. gracilis have highlighted unique metabolic pathways, which could provide new leads for product enhancement by genetic modification of the organism. Also, development of molecular tools for strain improvement are emerging rapidly, making E. gracilis a noteworthy challenger for microalgae such as Chlorella spp. and their products currently on the market.

KW - Euglena gracilis

KW - biosynthesis

KW - dietary protein

KW - vitamins

KW - polyunsaturated fatty acids

KW - wax esters

KW - paramylon

KW - large-scale cultivation

UR - http://purl.org/au-research/grants/arc/IC130100009

UR - http://www.scopus.com/inward/record.url?scp=85067580084&partnerID=8YFLogxK

U2 - 10.3389/fbioe.2019.00108

DO - 10.3389/fbioe.2019.00108

M3 - Review article

VL - 7

JO - Frontiers in Bioengineering and Biotechnology

JF - Frontiers in Bioengineering and Biotechnology

SN - 2296-4185

M1 - 108

ER -